Aktuelle smitsomme sygdomme
Søgeord (rsv) valgt.
154 emner vises.
-
Weekly respiratory virus update, week 14, March 2026Tilføjet 11. april 2026
-
RSV Shot Could Expand to All Adults in EUMedscape Infectious DiseasesTilføjet 2. april 2026
-
Weekly respiratory virus update, week 12, March 2026Tilføjet 28. marts 2026
-
Kids Confirmed as Top Transmitters of RSVMedscape Infectious DiseasesTilføjet 26. marts 2026
-
RSV Springs AheadMedscape Infectious DiseasesTilføjet 25. marts 2026
-
Parasitic Worms Provide Insights on RSV PreventionMedscape Infectious DiseasesTilføjet 24. marts 2026
-
Weekly respiratory virus update, week 11, March 2026Tilføjet 21. marts 2026
-
New ECDC Panel to Develop Adult RSV Vaccination GuidanceMedscape Infectious DiseasesTilføjet 17. marts 2026
-
FDA Approves Expanded Age Indication for RSV VaccineMedscape Infectious DiseasesTilføjet 17. marts 2026
-
GSK Gets US FDA Approval for Expanded Use Of RSV VaccineMedscape Infectious DiseasesTilføjet 14. marts 2026
-
Weekly respiratory virus update, week 10, March 2026Tilføjet 14. marts 2026
-
RSV Hospitalization Burden Rises With Age and ComorbiditiesMedscape Infectious DiseasesTilføjet 13. marts 2026
-
Immunofitness: Vaccination for Healthy AgingMedscape Infectious DiseasesTilføjet 13. marts 2026
-
mRNA RSV Vaccine Safe in Transplant RecipientsMedscape Infectious DiseasesTilføjet 10. marts 2026
-
Outpatient RSV in Kids Younger Than 2 Has Distinct FeaturesMedscape Infectious DiseasesTilføjet 10. marts 2026
-
Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case–control study, Spain, October 2023 to March 2025Eurosurveillance latest updatesTilføjet 6. marts 2026
-
Subunit RSV Vaccine Recommended for Adults Older Than 75Medscape Infectious DiseasesTilføjet 4. marts 2026
-
Weekly respiratory virus update, week 8, February 2026Tilføjet 28. februar 2026
-
RSV Tamps Down Rhinovirus Coinfection in InfantsMedscape Infectious DiseasesTilføjet 26. februar 2026
-
Response to RSV Varies With AgeMedscape Infectious DiseasesTilføjet 25. februar 2026
-
RSV Hits Harder in Kids With AsthmaMedscape Infectious DiseasesTilføjet 24. februar 2026
-
Weekly respiratory virus update, week 7, February 2026Tilføjet 21. februar 2026
-
RSV Vaccine in Multidose Vial Matches Single-Dose VialMedscape Infectious DiseasesTilføjet 19. februar 2026
-
RSV Admission May Raise Risk for Cardiorespiratory EventsMedscape Infectious DiseasesTilføjet 17. februar 2026
-
Weekly respiratory virus update, week 6, January 2026Tilføjet 13. februar 2026
-
Vaccine Trials Advance Pneumovirus PreventionMedscape Infectious DiseasesTilføjet 12. februar 2026
-
Weekly respiratory virus update, week 5, January 2026Tilføjet 7. februar 2026
-
RSV Antibody Levels Tied to Posttransplant Infection RiskMedscape Infectious DiseasesTilføjet 6. februar 2026
-
More Older Adults to Get RSV Vaccine During AprilMedscape Infectious DiseasesTilføjet 5. februar 2026
-
Weekly respiratory virus update, week 4, January 2026Tilføjet 30. januar 2026
-
Weekly respiratory virus update, week 3, January 2026Tilføjet 24. januar 2026
-
Preterm Birth Raises Risk for Severe RSV, Even at 36 WeeksMedscape Infectious DiseasesTilføjet 24. januar 2026
-
Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS)Eurosurveillance latest updatesTilføjet 16. januar 2026
-
Weekly respiratory virus update, week 2, January 2026Tilføjet 16. januar 2026
-
Weekly respiratory virus update, week 1, January 2026Tilføjet 9. januar 2026
-
RSV Prevention Products Show Effectiveness in US InfantsMedscape Infectious DiseasesTilføjet 6. januar 2026
-
Nirsevimab May Top Maternal Shot for Infants' RSV PreventionMedscape Infectious DiseasesTilføjet 5. januar 2026
-
What’s the Latest on Anti-RSV Monoclonal Antibodies in 2025?Medscape Infectious DiseasesTilføjet 18. december 2025
-
RSV Infection May Carry Extended Cardiovascular RiskMedscape Infectious DiseasesTilføjet 15. december 2025
-
Weekly respiratory virus update, week 49, November 2025Tilføjet 12. december 2025
-
Exclusive-US FDA Launches Fresh Safety Scrutiny Of Approved RSV Therapies for InfantsMedscape Infectious DiseasesTilføjet 9. december 2025
-
Maternal RSV Shot Linked to Fewer Infant HospitalisationsMedscape Infectious DiseasesTilføjet 9. december 2025
-
Weekly respiratory virus update, week 48, November 2025Tilføjet 7. december 2025
-
RSV Vaccine Effectiveness May Decline in Older VeteransMedscape Infectious DiseasesTilføjet 2. december 2025
-
Weekly respiratory virus update, week 47, November 2025Tilføjet 29. november 2025
-
Nirsevimab Offers Early RSV Protection in European ChildrenMedscape Infectious DiseasesTilføjet 25. november 2025
-
How Long Can Nirsevimab Protect Against RSV?Medscape Infectious DiseasesTilføjet 25. november 2025
-
Weekly respiratory virus update, week 46, November 2025Tilføjet 22. november 2025
-
Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025Morbidity and Mortality Weekly Report (MMWR)Tilføjet 21. november 2025
-
Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children agedEurosurveillance latest updatesTilføjet 17. november 2025